We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+17.18%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$2.45B
AUM Growth
–
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
92.72%
Top 10 Holdings %
Top 10 Hldgs %
26.73%
Holding
105
New
105
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$76M |
| 2 |
Texas Instruments
TXN
|
+$66.9M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$65M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$62.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$59.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.09% |
| 2 | Healthcare | 40.97% |
| 3 | Communication Services | 13.83% |
| 4 | Financials | 1.4% |
| 5 | Industrials | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Akebia Therapeutics
AKBA
$362M
| $8.04M | 0.33% |
+1,272,787
| New | +$6.05M |
|
77
Cisco
CSCO
$448B
| $7.7M | 0.31% |
+160,561
| New | +$7.46M |
|
78
Ascendis Pharma A/S
ASND
$16.5B
| $7.69M | 0.31% |
+55,284
| New | +$6.14M |
|
79
Neurocrine Biosciences
NBIX
$18.7B
| $7.68M | 0.31% |
+71,496
| New | +$7.49M |
|
|
P
80
Everpure Inc
P
$25B
| $7.68M | 0.31% |
+448,979
| New | +$7.94M |
|
81
Wolfspeed
WOLF
$1.24B
| $7.49M | 0.31% |
+162,208
| New | +$7.57M |
|
82
Knowles
KN
$3.08B
| $7.16M | 0.29% |
+338,495
| New | +$7.27M |
|
83
Baxter International
BAX
$13.8B
| $6.96M | 0.28% |
+83,228
| New | +$6.89M |
|
84
Coherent
COHR
$48.7B
| $6.73M | 0.28% |
+199,970
| New | +$6.37M |
|
|
MYOK
85
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.11M | 0.25% |
+83,823
| New | +$5.08M |
|
|
INFN
86
DELISTED
Infinera Corporation Common Stock
INFN
| $6.09M | 0.25% |
+766,573
| New | +$4.71M |
|
|
KDMN
87
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.76M | 0.24% |
+1,271,320
| New | +$4.65M |
|
88
Teradata
TDC
$2.88B
| $5.31M | 0.22% |
+198,497
| New | +$5.52M |
|
89
PayPal
PYPL
$49.3B
| $5.29M | 0.22% |
+48,862
| New | +$5.09M |
|
90
uniQure
QURE
$2.93B
| $5.26M | 0.21% |
+73,405
| New | +$4.03M |
|
91
Semtech
SMTC
$10.7B
| $5.22M | 0.21% |
+98,635
| New | +$4.94M |
|
92
Prothena Corp
PRTA
$440M
| $5.13M | 0.21% |
+324,005
| New | +$3.47M |
|
93
Immunovant
IMVT
$8.11B
| $4.32M | 0.18% |
+272,539
| New | +$3.05M |
|
|
CHNG
94
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $4.24M | 0.17% |
+258,386
| New | +$3.47M |
|
|
APLS
95
DELISTED
Apellis Pharmaceuticals
APLS
| $4.07M | 0.17% |
+132,947
| New | +$3.68M |
|
96
Travere Therapeutics
TVTX
$5.33B
| $4M | 0.16% |
+281,423
| New | +$3.59M |
|
97
Iovance Biotherapeutics
IOVA
$2.09B
| $3.95M | 0.16% |
+142,641
| New | +$3.24M |
|
|
TECX
98
Tectonic Therapeutic
TECX
$538M
| $3.86M | 0.16% |
+15,992
| New | +$3.08M |
|
99
TELA Bio
TELA
$31.8M
| $2.96M | 0.12% |
+228,534
| New | +$2.79M |
|
100
Abeona Therapeutics
ABEO
$369M
| $2.61M | 0.11% |
+31,890
| New | +$2.25M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Woodline Partners, which disclosed 105 positions worth $2.45B. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Seagen Inc. Common Stock: 716,700 shares worth $81.9M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, followed by Healthcare and Communication Services.
- Woodline Partners's largest Q4 2019 buy was Seagen Inc. Common Stock: 716,700 shares worth $81.9M.
- Woodline Partners's ten largest holdings make up 27% of its $2.45B portfolio in Q4 2019.
- Woodline Partners disclosed 105 positions in Q4 2019, its first 13F filing on record.
Based on Woodline Partners's 13F filing for Q4 2019, filed 14 Feb 2020.